Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Rotavirus outer capsid proteins VP4 and VP7, collectively known as the rotavirus surface/attachment antigens, form the outermost layer of the triple-layered rotavirus virion and are critical for viral infectivity. VP4 is a protease-sensitive spike protein that mediates the initial attachment of the virus to host cell surface receptors, such as sialic acids or histo-blood group antigens. VP7 is a calcium-dependent glycoprotein that forms the outer capsid shell and facilitates subsequent cell entry and membrane penetration. Together, these two proteins are the primary determinants of viral serotype (defining P and G genotypes, respectively) and serve as the major targets for neutralizing antibodies elicited by natural infection or vaccination. Currently, live attenuated rotavirus vaccines, such as Rotarix and RotaTeq, utilize these antigens to stimulate protective humoral and mucosal immune responses in infants, preventing severe dehydrating gastroenteritis. Therapeutic challenges include the high genetic diversity of VP4 and VP7 genotypes, which can lead to vaccine escape, and a rare but notable safety concern regarding vaccine-induced intussusception.
Active immunization via oral administration of live attenuated virus strains expressing VP4 and VP7 antigens, which stimulates the host immune system to produce neutralizing IgA and IgG antibodies that block viral attachment and penetration.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus outer capsid proteins VP4 and VP7 (VP4/VP7).